Concepedia

Rikke Holmgaard

RH

Statistics

Publications

18

Citations

3.1K

H-Index

18

Active since

2008

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Cornell University

Georgia Regents Medical Center

The University of Texas MD Anderson Cancer Center

Augusta University

Rikke Holmgaard is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, tumor immunology, and tumor biology.

ORCID

Top concepts

Publications per year

2008–2021

18

Publications

18

Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy

Dmitriy Zamarin, Rikke Holmgaard, Sumit K. Subudhi et al. · Science Translational Medicine · 2014 · 693 citations

, , +17

Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4

Rikke Holmgaard, Dmitriy Zamarin, David H. Munn et al. · The Journal of Experimental Medicine · 2013 · 625 citations · Full text

Tumor-Expressed IDO Recruits and Activates MDSCs in a Treg-Dependent Manner

Rikke Holmgaard, Dmitriy Zamarin, Yanyun Li et al. · Cell Reports · 2015 · 477 citations · Full text

Targeting the TGFβ pathway with galunisertib, a TGFβRI small molecule inhibitor, promotes anti-tumor immunity leading to durable, complete responses, as monotherapy and in combination with checkpoint blockade

Rikke Holmgaard, David Schaer, Yanxia Li et al. · Journal for ImmunoTherapy of Cancer · 2018 · 358 citations · Full text

The PTEN pathway in T <sub>regs</sub> is a critical driver of the suppressive tumor microenvironment

Madhav Sharma, Rahul Shinde, Tracy L. McGaha et al. · Science Advances · 2015 · 168 citations · Full text

, , +24

1–5 of 18